Azad, A., Arshad, M., Generali, D., Feldinger, K., Gijsen, M., Strina, C., . . . Kong, A. PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer. Wiley.
Chicago Style (17th ed.) CitationAzad, Abul, et al. PTPN9 Regulates HER3 Phosphorylation During Trastuzumab Treatment and Loss of PTPN9 Is a Potential Biomarker for Trastuzumab Resistance in HER2 Positive Breast Cancer. Wiley.
MLA (9th ed.) CitationAzad, Abul, et al. PTPN9 Regulates HER3 Phosphorylation During Trastuzumab Treatment and Loss of PTPN9 Is a Potential Biomarker for Trastuzumab Resistance in HER2 Positive Breast Cancer. Wiley.
Warning: These citations may not always be 100% accurate.